Showing results (1-10 of 438) with videos related to
Sort By:
Pageof 44
Medicinal Research Reviews|February 14, 2008
Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugsAna MartinezCurrent Opinion in Investigational Drugs (London, England : 2000)|July 31, 2007
Marine-derived drugs in neurologyAna MartinezExpert Opinion on Investigational Drugs|December 24, 2005
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's diseaseAna Martinez, Ana CastroExpert Opinion on Therapeutic Patents|October 7, 2014
cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseasesAna Martinez, Carmen GilCurrent Pharmaceutical Design|November 16, 2006
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitorsAna Castro, Ana MartinezExpert Opinion on Therapeutic Patents|November 10, 2016
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)Valle Palomo, Ana MartinezEuropean Journal of Medicinal Chemistry|October 21, 2018
Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseasesVanesa Nozal, Ana MartinezFrontiers in Molecular Neuroscience|November 9, 2011
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSHagit Eldar-Finkelman, Ana MartinezExpert Opinion on Investigational Drugs|February 10, 2023
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosisLoreto Martinez-Gonzalez, Ana MartinezJournal of Alzheimer'S Disease : JAD|October 28, 2008
GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease?Ana Martinez, Daniel I PerezPageof 44